)
)
)
Payal Agrawal Divakaran
Payal Agrawal Divakaran is a Partner at .406 Ventures, where she co-leads the healthcare investing practice. .406 Ventures is a Boston-based venture capital firm with over $1.3B under management. Since its founding in 2005, .406 Ventures has never wavered from its strategy of investing in early-stage enterprise-focused startups in healthcare, data + AI, and cybersecurity. Every member of the firm has deep operating or investing experience in these segments.
.406’s world-class founders and digital health companies are transforming healthcare technology and care delivery. Payal leads .406’s investments in AristaMD, Diana Health, Equip, FamilyWell, Heartbeat Health, Humata Health, Nema Health, Nomad Health, OncoveryCare, Vitalize Care, and Wellist. She has also supported Better Life Partners (acquired by Groups Recover Together), Laudio (acquired by Ascend Learning), Redox, Wayspring, and WelbeHealth.
Payal joined .406 after graduating from Harvard Business School, where she co-founded a company called SpotRocket to help students discover work opportunities at high potential startups. The company created a proprietary algorithm that ranked 20,000+ global startups and participated in the Rock Center Accelerator program; it was ultimately wound down.
During business school, Payal also spent time in Corporate Development at Eventbrite. She helped the company develop an M&A strategy and to navigate creating a market landscape, housing competitive intel, and setting processes for due diligence.
Prior to HBS, Payal was an Associate at Spectrum Equity, a technology growth equity investor in Boston. She sourced and executed on deals in the software, information services, data/analytics, security, and internet spaces. She sourced the firm’s first investment in online gaming in a business called Jagex, based in the UK, which was acquired by Shanghai Hongtou Network Technology.
Payal started her career pursuing technology investment banking at J.P. Morgan in NYC. She spent most of her time in the software and financial technology spaces and was an analyst on Xerox’s $8.3B acquisition of ACS.
Payal is a member of the Board of Trustees of Dana Farber Cancer Institute, a Venture Capital Advisor at HBS, an Advisory Board Member for Boston Children’s Hospital Innovation & Digital Health Accelerator, and a mentor for MIT Sandbox.
Payal received her MBA, with Distinction, from Harvard Business School and her BS in Electrical Engineering and minor in Management from MIT. She is a Boston native, grew up in Waltham and Dracut, and is a die-hard Celtics fan. Payal and her husband, who is a physician at Brigham and Women’s Hospital, have two children and live in Brookline.